Szuman M, Kaczmarek-Rys M, Hryhorowicz S, Kryszczynska A, Grot N, Plawski A
Int J Mol Sci. 2024; 25(15).
PMID: 39125905
PMC: 11313073.
DOI: 10.3390/ijms25158338.
Jafrin S, Aziz M, Islam M
J Int Med Res. 2022; 50(10):3000605221133173.
PMID: 36314251
PMC: 9623385.
DOI: 10.1177/03000605221133173.
Pan H, Gu X, Wang X, Gao Z, Ding G, Zou C
BMC Med Genomics. 2022; 15(1):14.
PMID: 35073920
PMC: 8785439.
DOI: 10.1186/s12920-021-01151-2.
Blanchet A, Bourgmayer A, Kurtz J, Mellitzer G, Gaiddon C
Cancers (Basel). 2021; 13(4).
PMID: 33671606
PMC: 7926742.
DOI: 10.3390/cancers13040916.
Meng J, Wang S, Zhang M, Fan S, Zhang L, Liang C
Biosci Rep. 2018; 38(6).
PMID: 30420492
PMC: 6294616.
DOI: 10.1042/BSR20181452.
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Dong Z, Zheng L, Liu W, Wang C
Cancer Manag Res. 2018; 10:1341-1349.
PMID: 29872345
PMC: 5973318.
DOI: 10.2147/CMAR.S164892.
Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309 with non-small cell lung cancer risk in a Chinese population.
Li W, Wang S, Deng J, Tang J
Oncol Lett. 2017; 14(2):1817-1822.
PMID: 28789416
PMC: 5529775.
DOI: 10.3892/ol.2017.6327.
Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia.
Li M, Wang D, Wang Y, Sun G, Song W, Zhang B
Oncol Lett. 2017; 14(2):1484-1490.
PMID: 28789369
PMC: 5529880.
DOI: 10.3892/ol.2017.6374.
The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X, Dai S, Sun J, Jiang S, Jiang Y
Oncotarget. 2016; 8(1):1156-1165.
PMID: 27901479
PMC: 5352043.
DOI: 10.18632/oncotarget.13589.
TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
Abderrahmane R, Louhibi L, Moghtit F, Boubekeur A, Benseddik K, Boudjema A
Pathol Oncol Res. 2014; 21(3):629-35.
PMID: 25537146
DOI: 10.1007/s12253-014-9867-6.
Impact of p73 gene polymorphism on cancer susceptibility: a meta analysis.
Liu Y, Dong W, Mou Q, Leng Y, Zhang L, Duan L
Int J Clin Exp Pathol. 2014; 7(10):6820-5.
PMID: 25400764
PMC: 4230064.
Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.
Carastro L, Lin H, Park H, Kim D, Radlein S, Hampton K
Prostate Cancer. 2014; 2014:129582.
PMID: 25097786
PMC: 4109114.
DOI: 10.1155/2014/129582.
p73 G4C14-to-A4T14 polymorphisms are positively correlated with triple-negative breast cancer in southwestern China.
Zhou X
Med Oncol. 2013; 30(2):515.
PMID: 23443851
DOI: 10.1007/s12032-013-0515-x.
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.
Deng B, Liu F, Wei Y, Luo L, Chen X, Yan L
Tumour Biol. 2012; 34(1):293-9.
PMID: 23065572
DOI: 10.1007/s13277-012-0550-9.
Alterations of the TP53 gene in gastric and esophageal carcinogenesis.
Bellini M, Cadamuro A, Succi M, Proenca M, Silva A
J Biomed Biotechnol. 2012; 2012:891961.
PMID: 22919278
PMC: 3420349.
DOI: 10.1155/2012/891961.
Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case-control study.
Zhang Y, Liu L, Tang Y, Chen C, Wang Q, Xu J
Mol Biol Rep. 2012; 39(10):9661-8.
PMID: 22744426
DOI: 10.1007/s11033-012-1831-5.
An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.
Liu K, Qi H, Yao H, Lei S, Lei Z, Li T
Mol Biol Rep. 2012; 39(8):8265-75.
PMID: 22707142
DOI: 10.1007/s11033-012-1674-0.
Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study.
Zhou X, Wu C
Med Oncol. 2012; 29(5):3216-21.
PMID: 22535334
DOI: 10.1007/s12032-012-0240-x.
Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.
Wang L, Gao R, Yu L
Mol Biol Rep. 2011; 39(2):1731-8.
PMID: 21617940
DOI: 10.1007/s11033-011-0913-0.
Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.
Umar M, Upadhyay R, Khurana R, Kumar S, Ghoshal U, Mittal B
Mol Biol Rep. 2011; 39(2):1153-62.
PMID: 21573788
DOI: 10.1007/s11033-011-0844-9.